About Ribonaut Therapeutics
Ribonaut Therapeutics is a private company based in Jupiter, Florida, incorporated in 2022 in Delaware. It has reported $6,917,854 raised in one offering on Form D since January 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2022 | Jan 4, 2023 | $6,917,854of $25.9M target | 6 | $1.1M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ribonaut Therapeutics's Form D filed Jan 4, 2023.
ZC
Zachary Collins
Executive officer
ST
Steven Tregay
Director
MD
Matthew Disney
Executive officer and director
LL
Lusong Luo
Director
JD
Jessica Childs-Disney
Promoter